Prior to the cannabis treatment, the mice contained high levels of Akkermansia muciniphila, a bacteria that increases production of lipopolysaccharides, a compound that has been associated with brain inflammation. However, following cannabis treatment, the mice decreased populations of this gut microbiomes in their gut as well as reduced levels of lipopolysaccharides in the brain.